SARS-CoV-2–host proteome interactions for antiviral drug discovery
dc.contributor.affiliation | University of Helsinki-Markku Varjosalo | |
dc.contributor.author | Markku Varjosalo | |
dc.date.accessioned | 2025-04-29T13:59:34Z | |
dc.date.issued | 2021-09-29 | |
dc.date.issued | 2021-09-29 | |
dc.description | Images and datasets used in Fig 6 and corresponding supplementary material Image analysis was performed with Harmony 4.9 software (PerkinElmer) with feature extraction and linear classification of N-protein positive cells from the total population as presented in the PlateResults file. Prism files (GraphPad Software) include the calculations for curve fits of drug testing data (4PL logistic regression) as well as area under the curve (AUC) of the fitted curves.. | |
dc.identifier | https://doi.org/10.5281/zenodo.5534941 | |
dc.identifier.uri | https://datakatalogi.helsinki.fi/handle/123456789/4356 | |
dc.rights.license | cc-by-4.0 | |
dc.subject | Functional drug testing | |
dc.subject | Image-based drug testing | |
dc.subject | curve fit | |
dc.subject | AUC | |
dc.title | SARS-CoV-2–host proteome interactions for antiviral drug discovery | |
dc.type | dataset |